161 related articles for article (PubMed ID: 35426542)
1. RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis.
Kim D; Bae SJ; Ahn SG; Jeong J; Park S; Park WC; Park G; Lee S; Yoon CI
Breast Cancer Res Treat; 2022 Jun; 193(3):637-647. PubMed ID: 35426542
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
3. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
4. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
BMC Cancer; 2018 Nov; 18(1):1137. PubMed ID: 30453914
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
7. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
Cong X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
[TBL] [Abstract][Full Text] [Related]
8. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With Gastric Cancer who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Numata M; Morita J; Tanabe M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1567-1574. PubMed ID: 38537996
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma.
Tian Y; Zhang Y; Zhu WQ; Chen XL; Zhou HB; Chen WM
Biomed Res Int; 2018; 2018():9434637. PubMed ID: 30599001
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia using pectoralis muscle area and lymphocyte-to-monocyte ratio (LMR) are independent prognostic factors in patients for nonmetastatic breast cancer.
Song HN; Kim JY; Kim JM; Kang KM; Choi HS; Jeong JH; Ha IB; Jeong BK
Medicine (Baltimore); 2022 Dec; 101(49):e32229. PubMed ID: 36626455
[TBL] [Abstract][Full Text] [Related]
12. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
14. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
16. Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1-IIa cervical cancer patients who undergo radical surgery.
Chen L; Zhang F; Sheng XG; Zhang SQ
Onco Targets Ther; 2015; 8():1355-62. PubMed ID: 26089685
[TBL] [Abstract][Full Text] [Related]
17. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer.
Zhou X; Du Y; Xu J; Huang Z; Qiu T; Wang X; Qian J; Zhu W; Liu P
Tumour Biol; 2014 Nov; 35(11):11659-66. PubMed ID: 25139101
[TBL] [Abstract][Full Text] [Related]
18. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]